Pharmaceutics - Medika Life

European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Colorado Charts Its Own Course on Vaccines Amid Federal Pullback

Medika Life - May 25, 2026

In response to abrupt and politicized changes to federal vaccine policy, concerned Coloradans have taken several steps to shore up support for vaccine science. A bill passed...

Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

Medika Life - August 6, 2020

CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Did We Get Hormone Therapy Wrong?

Colorado Charts Its Own Course on Vaccines Amid Federal Pullback

Of Measles and Midterms

BIO – Biotech Without Borders

LATEST

TRENDING

The Evolution of Quinine to Hydroxychloroquine, Covid’s Snake Oil

Ten mRNA Facts You Probably Didn’t Know About and Ten Nonsenses

Ten Facts You Didn’t Know About Moderna and Their mRNA Vaccine

Adrenochrome, Satanic Masses, Abducted Children and Urban Legends

Phexxi; Have You Heard About This New Hormone-Free Contraceptive?

Killing The Coronavirus. A New Treatment Shows 99.9 Percent Efficacy

Ivermectin is NOT Hydroxychloroquine. Why is the FDA Ignoring a Potential Covid Treatment?

Kratom is an Unregulated Addictive Drug That Kills

Healthcare Workers Show Their Faith in the Covid Vaccine #vaccinechallenge

Oriahnn; A Drug to Stop Heavy Periods for Women With Fibroids

EDITORS CHOICE

Krispy Kreme Offers Free Doughnuts to Promote Covid-19 Vaccinations

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Colorado Charts Its Own Course on Vaccines Amid Federal Pullback

Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories